MedTrace Logo

Sensory Symptoms in Active Vitiligo

NCT05390164 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-05-25

No results posted yet for this study

Summary

This work aims to assess sensory symptoms in early active vitiligo patients (segmental, non-segmental, or mixed) and to measure 3 neuropeptides expression in their lesional skin \[neuropeptide Y(NPY), calcitonin gene-related peptide (CGRP), and nerve growth factors (NGF)\] to correlate neuropeptide levels, sensory symptoms, and functions, with criteria of disease activity and perceived stress scale.

Conditions

  • Totest Sensory Symptoms in Active Vitiligo

Interventions

DIAGNOSTIC_TEST

skin biopsy

skin biopsy to be analyzed by ELISA

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2022-08-15
Completion
2022-08-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05390164 on ClinicalTrials.gov